IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v16y2019i9p1592-d228778.html
   My bibliography  Save this article

Estimated Impact of Targeted Pre-Exposure Prophylaxis: Strategies for Men Who Have Sex with Men in the United States

Author

Listed:
  • Richard A. Elion

    (George Washington University School of Medicine, Washington, DC 20009, USA)

  • Mina Kabiri

    (Precision Health Economics, Los Angeles, CA 90025, USA)

  • Kenneth H. Mayer

    (The Fenway Institute, Harvard Medical School, Boston, MA 02215, USA)

  • David A. Wohl

    (Chapel Hill School of Medicine, The University of North Carolina, Chapel Hill, NC 27514, USA)

  • Joshua Cohen

    (Tufts University Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA 02111, USA)

  • Anne C. Beaubrun

    (Gilead Sciences, Foster City, CA 94404, USA)

  • Frederick L. Altice

    (Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT 06510, USA)

Abstract

Pre-exposure prophylaxis (PrEP) effectively reduces human immunodeficiency virus (HIV) transmission. We aimed to estimate the impact of different PrEP prioritization strategies among Black and Latino men who have sex with men (MSM) in the United States, populations most disproportionately affected by HIV. We developed an agent-based simulation to model the HIV epidemic among MSM. Individuals were assigned an HIV incidence risk index (HIRI-MSM) based on their sexual behavior. Prioritization strategies included PrEP use for individuals with HIRI-MSM ≥10 among all MSM, all Black MSM, young (≤25 years) Black MSM, Latino MSM, and young Latino MSM. We estimated the number needed to treat (NNT) to prevent one HIV infection, reductions in prevalence and incidence, and subsequent infections in non-PrEP users avoided under these strategies over 5 years (2016–2020). Young Black MSM eligible for PrEP had the lowest NNT (NNT = 10) followed by all Black MSM (NNT = 33) and young Latino MSM (NNT = 35). All Latino MSM and all MSM had NNT values of 63 and 70, respectively. Secondary infection reduction with PrEP was the highest among young Latino MSM (53.2%) followed by young Black MSM (37.8%). Targeting all MSM had the greatest reduction in prevalence (14.7% versus 2.9%–3.9% in other strategies) and incidence (49.4% versus 9.4%–13.9% in other groups). Using data representative of the United States MSM population, we found that a strategy of universal PrEP use by MSM was most effective in reducing HIV prevalence and incidence of MSM. Targeted use of PrEP by Black and Latino MSM, however, especially those ≤25 years, had the greatest impact on HIV prevention.

Suggested Citation

  • Richard A. Elion & Mina Kabiri & Kenneth H. Mayer & David A. Wohl & Joshua Cohen & Anne C. Beaubrun & Frederick L. Altice, 2019. "Estimated Impact of Targeted Pre-Exposure Prophylaxis: Strategies for Men Who Have Sex with Men in the United States," IJERPH, MDPI, vol. 16(9), pages 1-14, May.
    • Handle: RePEc:gam:jijerp:v:16:y:2019:i:9:p:1592-:d:228778
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/16/9/1592/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/16/9/1592/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Gabriela B Gomez & Annick Borquez & Kelsey K Case & Ana Wheelock & Anna Vassall & Catherine Hankins, 2013. "The Cost and Impact of Scaling Up Pre-exposure Prophylaxis for HIV Prevention: A Systematic Review of Cost-Effectiveness Modelling Studies," PLOS Medicine, Public Library of Science, vol. 10(3), pages 1-16, March.
    2. Anders Chen & David W Dowdy, 2014. "Clinical Effectiveness and Cost-Effectiveness of HIV Pre-Exposure Prophylaxis in Men Who Have Sex with Men: Risk Calculators for Real-World Decision-Making," PLOS ONE, Public Library of Science, vol. 9(10), pages 1-9, October.
    3. Hall, H.I. & Byers, R.H. & Ling, Q. & Espinoza, L., 2007. "Racial/ethnic and age disparities in HIV prevalence and disease progression among men who have sex with men in the United States," American Journal of Public Health, American Public Health Association, vol. 97(6), pages 1060-1066.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Sabina S Alistar & Douglas K Owens & Margaret L Brandeau, 2014. "Effectiveness and Cost Effectiveness of Oral Pre-Exposure Prophylaxis in a Portfolio of Prevention Programs for Injection Drug Users in Mixed HIV Epidemics," PLOS ONE, Public Library of Science, vol. 9(1), pages 1-11, January.
    2. Stuart J. Wright & William G. Newman & Katherine Payne, 2019. "Accounting for Capacity Constraints in Economic Evaluations of Precision Medicine: A Systematic Review," PharmacoEconomics, Springer, vol. 37(8), pages 1011-1027, August.
    3. Xiao Zang & Emanuel Krebs & Linwei Wang & Brandon D. L. Marshall & Reuben Granich & Bruce R. Schackman & Julio S. G. Montaner & Bohdan Nosyk, 2019. "Structural Design and Data Requirements for Simulation Modelling in HIV/AIDS: A Narrative Review," PharmacoEconomics, Springer, vol. 37(10), pages 1219-1239, October.
    4. Zixin Wang & Yuan Fang & Natthakhet Yaemim & Kai J. Jonas & Andrew Chidgey & Mary Ip & Tommy Cheng & Joseph T. F. Lau, 2021. "Factors Predicting Uptake of Sexually Transmitted Infections Testing among Men Who Have Sex with Men Who Are “Pre-Exposure Prophylaxis Tourists”—An Observational Prospective Cohort Study," IJERPH, MDPI, vol. 18(7), pages 1-15, March.
    5. Ghayoori, Arash & Nagi, Rakesh, 2022. "A Markov model examining intervention effects on the HIV prevalence/incidence amongst the overall population," Socio-Economic Planning Sciences, Elsevier, vol. 79(C).
    6. Terris-Prestholt, Fern & Mulatu, Abay & Quaife, Matthew & Gafos, Mitzy & Medley, Graham F. & MacPhail, Catherine & Hanson, Kara, 2021. "Using choice experiments to improve equity in access to socially marketed HIV prevention products," Journal of choice modelling, Elsevier, vol. 41(C).
    7. Tom L. Drake & Angela Devine & Shunmay Yeung & Nicholas P. J. Day & Lisa J. White & Yoel Lubell, 2016. "Dynamic Transmission Economic Evaluation of Infectious Disease Interventions in Low‐ and Middle‐Income Countries: A Systematic Literature Review," Health Economics, John Wiley & Sons, Ltd., vol. 25(S1), pages 124-139, February.
    8. Johannes Bullinger & Thijs Reyniers & Bea Vuylsteke & Marie Laga & Christiana Nöstlinger, 2019. "Congruence between Hypothetical Willingness to Use Pre-Exposure Prophylaxis (PrEP) and Eligibility: An Online Survey among Belgian Men Having Sex with Men," IJERPH, MDPI, vol. 16(22), pages 1-15, November.
    9. Jennie McKenney & Anders Chen & Karen W Hoover & Jane Kelly & David Dowdy & Parastu Sharifi & Patrick S Sullivan & Eli S Rosenberg, 2017. "Optimal costs of HIV pre-exposure prophylaxis for men who have sex with men," PLOS ONE, Public Library of Science, vol. 12(6), pages 1-13, June.
    10. Alexandra M Oster & Kate Russell & Ryan E Wiegand & Eduardo Valverde & David W Forrest & Melissa Cribbin & Binh C Le & Gabriela Paz-Bailey & NHBS Study Group, 2013. "HIV Infection and Testing among Latino Men Who Have Sex with Men in the United States: The Role of Location of Birth and Other Social Determinants," PLOS ONE, Public Library of Science, vol. 8(9), pages 1-9, September.
    11. Matthew Quaife & Robyn Eakle & Maria A. Cabrera Escobar & Peter Vickerman & Maggie Kilbourne-Brook & Mercy Mvundura & Sinead Delany-Moretlwe & Fern Terris-Prestholt, 2018. "Divergent Preferences for HIV Prevention: A Discrete Choice Experiment for Multipurpose HIV Prevention Products in South Africa," Medical Decision Making, , vol. 38(1), pages 120-133, January.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:16:y:2019:i:9:p:1592-:d:228778. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.